Francesca Elice

2.1k total citations
32 papers, 1.2k citations indexed

About

Francesca Elice is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Francesca Elice has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 16 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Francesca Elice's work include Multiple Myeloma Research and Treatments (17 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Francesca Elice is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Francesca Elice collaborates with scholars based in Italy, United States and Netherlands. Francesca Elice's co-authors include Francesco Rodeghiero, Guido Tricot, Maurizio Zangari, Louis M. Fink, Bart Barlogie, Frederick R. Rickles, Anna Falanga, Dorothy Adcock, Fenghuang Zhan and Michael J. Burns and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Francesca Elice

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Elice Italy 17 654 455 440 252 203 32 1.2k
Mieczysław Komarnicki Poland 19 580 0.9× 483 1.1× 384 0.9× 410 1.6× 160 0.8× 97 1.4k
J L Francis United States 19 481 0.7× 275 0.6× 230 0.5× 113 0.4× 368 1.8× 38 1.2k
A.K. Kakkar United Kingdom 13 376 0.6× 269 0.6× 273 0.6× 112 0.4× 508 2.5× 28 1.0k
Julia E. Geddings United States 10 352 0.5× 356 0.8× 192 0.4× 78 0.3× 425 2.1× 13 953
J. Rifón Spain 18 515 0.8× 641 1.4× 316 0.7× 361 1.4× 47 0.2× 60 1.5k
Alfonso Vignoli Italy 12 422 0.6× 457 1.0× 97 0.2× 572 2.3× 274 1.3× 25 1.1k
Robert F. Cornell United States 21 892 1.4× 726 1.6× 598 1.4× 179 0.7× 57 0.3× 80 1.3k
Clara Klerk Netherlands 9 279 0.4× 245 0.5× 196 0.4× 91 0.4× 535 2.6× 18 1.1k
Leonard T. Heffner United States 21 1.1k 1.6× 687 1.5× 717 1.6× 299 1.2× 68 0.3× 68 1.7k
Jean‐Marc Zini France 15 492 0.8× 173 0.4× 128 0.3× 219 0.9× 56 0.3× 33 867

Countries citing papers authored by Francesca Elice

Since Specialization
Citations

This map shows the geographic impact of Francesca Elice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Elice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Elice more than expected).

Fields of papers citing papers by Francesca Elice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Elice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Elice. The network helps show where Francesca Elice may publish in the future.

Co-authorship network of co-authors of Francesca Elice

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Elice. A scholar is included among the top collaborators of Francesca Elice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Elice. Francesca Elice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montemurro, Tiziana, Cristiana Lavazza, Elisa Montelatici, et al.. (2024). Off-the-Shelf Cord-Blood Mesenchymal Stromal Cells: Production, Quality Control, and Clinical Use. Cells. 13(12). 1066–1066. 3 indexed citations
2.
Astori, Giuseppe, M. Bernardi, Daniela Catanzaro, et al.. (2020). Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice. Journal of Translational Medicine. 18(1). 451–451. 4 indexed citations
3.
Chieregato, Katia, Alberta Alghisi, Carlo Borghero, et al.. (2015). Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay. Transfusion and Apheresis Science. 53(2). 242–245. 4 indexed citations
4.
Elice, Francesca & Francesco Rodeghiero. (2012). Side effects of anti-angiogenic drugs. Thrombosis Research. 129. S50–S53. 105 indexed citations
5.
Elice, Francesca & Francesco Rodeghiero. (2011). Hematologic malignancies and thrombosis. Thrombosis Research. 129(3). 360–366. 32 indexed citations
6.
Elice, Francesca & Francesco Rodeghiero. (2010). Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact. Thrombosis Research. 125. S55–S57. 35 indexed citations
7.
Zangari, Maurizio, Francesca Elice, Guido Tricot, & Louis M. Fink. (2009). Bleeding Disorders Associated with Cancer Dysproteinemias. Cancer treatment and research. 148. 295–304. 2 indexed citations
8.
Elice, Francesca, Francesco Rodeghiero, Anna Falanga, & Frederick R. Rickles. (2009). Thrombosis associated with angiogenesis inhibitors. Best Practice & Research Clinical Haematology. 22(1). 115–128. 98 indexed citations
9.
Zangari, Maurizio, Francesca Elice, Guido Tricot, & Louis M. Fink. (2008). Thrombophilia. SHILAP Revista de lepidopterología. 3. DTI.S568–DTI.S568. 4 indexed citations
10.
Elice, Francesca, et al.. (2008). Hemostatic complications of angiogenesis inhibitors in cancer patients. American Journal of Hematology. 83(11). 862–870. 56 indexed citations
11.
Zangari, Maurizio, Dixie Esseltine, Federica Cavallo, et al.. (2007). Predictive value of alkaline phosphatase for response and time to progression in bortezomib‐treated multiple myeloma patients. American Journal of Hematology. 82(9). 831–833. 23 indexed citations
12.
Zangari, Maurizio, Francesca Elice, Louis M. Fink, & Guido Tricot. (2007). Hemostatic Dysfunction in Paraproteinemias and Amyloidosis. Seminars in Thrombosis and Hemostasis. 33(4). 339–349. 45 indexed citations
13.
Elice, Francesca, Louis M. Fink, Guido Tricot, Bart Barlogie, & Maurizio Zangari. (2006). Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism. British Journal of Haematology. 134(4). 399–405. 108 indexed citations
14.
Elice, Francesca, R Raimondi, Alberto Tosetto, et al.. (2006). Prolonged overall survival with second on-demand autologous transplant in multiple myeloma. American Journal of Hematology. 81(6). 426–431. 46 indexed citations
15.
Zangari, Maurizio, Dixie Esseltine, Choon‐Kee Lee, et al.. (2005). Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma. British Journal of Haematology. 131(1). 71–73. 146 indexed citations
16.
Zangari, Maurizio, Francesca Elice, & Guido Tricot. (2005). Immunomodulatory drugs in multiple myeloma. Expert Opinion on Investigational Drugs. 14(11). 1411–1418. 16 indexed citations
17.
Zangari, Maurizio, Kevin B. Najarian, Dixie Esseltine, et al.. (2005). The Anti-Myeloma Effect of Bortezomib Is Associated with Osteoblastic Activity.. Blood. 106(11). 510–510. 2 indexed citations
18.
Cairoli, Roberto, Alessandro Beghini, Gianpaolo Nadali, et al.. (2004). Prognostic Impact of C-Kit Mutations in Core Binding Factor-Leukemia.. Blood. 104(11). 2013–2013. 9 indexed citations
19.
Beghini, Alessandro, Carla B. Ripamonti, Roberto Cairoli, et al.. (2004). KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.. PubMed. 89(8). 920–5. 125 indexed citations
20.
Rodeghiero, Francesco & Francesca Elice. (2003). Thalidomide and Thrombosis. Pathophysiology of Haemostasis and Thrombosis. 33(1). 15–18. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mieczysław Komarnicki Breakdown of academic impact, for papers by J L Francis Breakdown of academic impact, for papers by A.K. Kakkar Breakdown of academic impact, for papers by Julia E. Geddings Breakdown of academic impact, for papers by J. Rifón Breakdown of academic impact, for papers by Alfonso Vignoli Breakdown of academic impact, for papers by Robert F. Cornell Breakdown of academic impact, for papers by Clara Klerk Breakdown of academic impact, for papers by Leonard T. Heffner Breakdown of academic impact, for papers by Jean‐Marc Zini
Rankless by CCL
2026